Cargando…

Electronic health record derived-impact of COVID-19 on myasthenia gravis

Detalles Bibliográficos
Autores principales:	Roy, Bhaskar, Kovvuru, Sukanthi, Nalleballe, Krishna, Onteddu, Sanjeeva Reddy, Nowak, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895699/ https://www.ncbi.nlm.nih.gov/pubmed/33639420 http://dx.doi.org/10.1016/j.jns.2021.117362

Ejemplares similares

Risk of coronavirus disease 2019 (COVID-19) from hospital admission during the pandemic
por: Nalleballe, Krishna, et al.
Publicado: (2020)

Impact of cerebral venous sinus thrombosis associated with COVID-19
por: Hinduja, Archana, et al.
Publicado: (2021)

COVID-19 in patients with neurological disorders
por: Onteddu, Sanjeeva Reddy, et al.
Publicado: (2020)

Biologics in systemic autoimmune diseases during COVID-19 pandemic
por: Annapureddy, Narender, et al.
Publicado: (2020)

Immunosuppression in chronic autoimmune neurological disorders during the COVID-19 pandemic
por: Kovvuru, Sukanthi, et al.
Publicado: (2021)

Resident Education During COVID-19 Pandemic: Effectiveness of Virtual Electroencephalogram Learning
por: Yadala, Sisira, et al.
Publicado: (2020)

Before attributing COVID_19-related ischemic stroke to hypercoagulability alternative causes should be excluded
por: Elkhider, Hisham, et al.
Publicado: (2020)

Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
por: Nalleballe, Krishna, et al.
Publicado: (2020)

Spectrum of neuropsychiatric manifestations in COVID-19
por: Nalleballe, Krishna, et al.
Publicado: (2020)

Outcomes of COVID-19 in Solid Organ Transplants
por: Ranabothu, Saritha, et al.
Publicado: (2020)

Myasthenia gravis: A challenge
por: Ramesh, Bhagyalakshmi
Publicado: (2015)

Subgroup Classification of Myasthenia Gravis
por: Renjen, Pushpendra N.
Publicado: (2021)

Critically ill neurologic patients during the COVID-19 pandemic: A short communication
por: Shah, Vishank Arun, et al.
Publicado: (2021)

Nephrotic syndrome after thymectomy for myasthenia gravis
por: Kute, V. B., et al.
Publicado: (2013)

The perianaesthetic management of a patient with myasthenia gravis
por: Singh, Anisha, et al.
Publicado: (2023)

Management of thoracoscopic thymectomy in a myasthenia gravis patient
por: Adate, Kavita, et al.
Publicado: (2011)

Hydroxychloroquine and Myasthenia Gravis-Can One Take This Risk?
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2020)

A review of pathophysiology and neuropsychiatric manifestations of COVID-19
por: Jasti, Madhu, et al.
Publicado: (2020)

Long-term treatment of refractory myasthenia gravis with subcutaneous immunoglobulin
por: Kovács, Edina, et al.
Publicado: (2017)

Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis
por: Garnero, Martina, et al.
Publicado: (2018)

Favipiravir Experience in Covid-19 Positive Myasthenia Gravis Patients
por: Yevgi, Recep, et al.
Publicado: (2021)

New-Onset Myasthenia Gravis Following COVID-19 Vaccination
por: Özenç, Betül, et al.
Publicado: (2022)

Sweet taste loss in myasthenia gravis: more than a coincidence?
por: Chabwine, Joelle N, et al.
Publicado: (2014)

Myasthenia Gravis Associated with Acute Hepatitis E Infection in Immunocompetent Woman
por: Belbezier, Aude, et al.
Publicado: (2014)

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report
por: Rahul, L Yadav, et al.
Publicado: (2017)

Acute encephalopathy is associated with worse outcomes in COVID-19 patients
por: Shah, Vishank Arun, et al.
Publicado: (2020)

Emergency cesarian section in a patient of myasthenia gravis: Is neuraxial anesthesia safe?
por: Mundada, Surbhi D., et al.
Publicado: (2012)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Oculopharyngeal muscular dystrophy misdiagnosed as myasthenia gravis: Case report and review of literature
por: Aryani, Omid, et al.
Publicado: (2017)

Clinical characteristics and outcomes of patients with overlapping Miller Fisher syndrome and myasthenia gravis
por: Yuan, Jun-Liang, et al.
Publicado: (2019)

Interplay between Myasthenia Gravis and Severe COVID-19 Infection: The Missing Links
por: Singh, Shalendra, et al.
Publicado: (2022)

Seronegative Myasthenia Gravis in Association with Human T-Lymphotropic Virus Type 1 and Hepatitis C
por: Amin, Saad Muhammad, et al.
Publicado: (2019)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
por: Schneider-Gold, Christiane, et al.
Publicado: (2017)

Systemic Lupus Erythematosus and Myasthenia Gravis in a Male Patient: an HLA Case Investigated
por: Klimi, Eleni, et al.
Publicado: (2021)

Myasthenia Gravis in the Setting of Immune Checkpoint Inhibitor Therapy: Practical Considerations and Opinion-Based Approach to Acute Management
por: Zubair, Adeel S, et al.
Publicado: (2022)

Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Le Panse, Rozen
Publicado: (2017)

Successful administration of electroconvulsive therapy in a patient with treatment-resistant schizophrenia and coexisting myasthenia gravis
por: Sreeraj, Vanteemar S., et al.
Publicado: (2019)

Cholinergic neuromuscular hyperactivity in a patient with anti-muscle-specific tyrosine kinase myasthenia gravis
por: Okhovat, Ali Asghar, et al.
Publicado: (2020)

Progressive Bulbar Palsy with Facial Diplegia and Proximal Weakness Diagnosed as Juvenile-Onset Myasthenia Gravis
por: Verma, Rajesh, et al.
Publicado: (2023)

Clinical Characteristics of Refractory Myasthenia Gravis Patients
por: Suh, Joome, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0osjl18bg5a5clb0l6br3vq4ah